Witness Testimony Regarding Intent to Infringe Excluded Because Defendant Refused Such Discovery Based on Privilege

Jan 17, 2023

Reading Time : 2 min

By: Jason Weil, Rachel J. Elsby, Lisa Hladik (Law Clerk)

In this case, plaintiffs alleged that defendant’s generic drug infringed its patent covering a method of treating hair loss. Before trial, plaintiffs filed two motions in limine seeking to exclude (1) evidence of prior litigation and (2) evidence related to defendant’s intent to infringe. The court granted plaintiffs’ first motion in limine to exclude evidence of the prior lawsuits because, inter alia, the evidence was more prejudicial than probative.

In the second motion in limine, plaintiffs moved to exclude defendant’s evidence relating to its executives’ “business understanding” as to whether it was entitled to practice the methods claimed in the asserted patent. Plaintiffs argued that the executives obtained their understanding from legal counsel, and that it should be excluded because defendant refused discovery of the same evidence based on privileged. The defendant responded that its executives’ understanding was based on public information, including the litigation history between the parties, and therefore did not fall within the scope of information it previously withheld as privileged.

To evaluate the arguments, the district court grouped the evidence defendants sought to introduce into three categories: (1) statements that the plaintiffs had “thrown in the towel” after losing three previous lawsuits between the parties, (2) statements by the defendant’s legal department giving it the go-ahead to launch its generic product and (3) statements related to the outcome of the prior litigation. According to the district court, the evidence in each category would only be admissible if it was either the subject of a waiver or not derived from advice of counsel.

As to the first two categories of evidence, the district court found the statements were clearly derived from advice of counsel. In particular, defendant’s understanding that plaintiffs were “throwing in the towel” and that it had the “green light” to practice the claims was not public information, and must have been obtained from counsel. Because defendant refused discovery into advice it received from counsel, it was precluded from presenting testimony from its executives about their “business understanding” of that advice at trial. As to the third category, the district court found the executives’ understanding regarding the outcome of prior litigation was based on public information, and therefore not privileged even if obtained from counsel. But that finding did not save defendant because the district court separately excluded testimony related to prior litigation through plaintiffs’ first motion in limine.

Practice Tip: In cases involving allegations of willful, contributory or induced infringement, defendants face a difficult choice of whether to waive privilege or potentially face trial without exculpatory evidence regarding their scienter. Thus, it is important to develop an early understanding of the evidence that may be relied on to negate allegations of intent and the source of that evidence to make informed decisions related to privilege during discovery. Likewise, patentees should take deliberate steps in discovery to ensure that defendants are forced to choose whether to waive privilege or forego such evidence.

Share This Insight

Previous Entries

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

IP Newsflash

March 12, 2026

The District of New Jersey recently denied the litigants’ request for a briefing schedule to resolve a dispute about a proposed discovery confidentiality order, and also denied extending the deadlines for the defendants’ invalidity and non-infringement contentions. At issue was the scope of the FDA and patent prosecution bars in the confidentiality order.

...

Read More

IP Newsflash

February 27, 2026

The USPTO Director denied a patent owner’s request for discretionary denial of two inter partes review (IPR) petitions, citing the petitioner’s “well-settled expectation” that it would not be accused of infringing the two challenged patents. The Director’s conclusion was based on the petitioner’s decade-long business relationship with the original owner of the challenged patents.

...

Read More

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.